您的位置: 首页 > 农业专利 > 详情页

Derived from fused tricyclic imidazoles as modulators of TNF activity
专利权人:
UCB Biopharma SRL
发明人:
ALEXANDER, Rikki Peter,BRACE, Gareth Neil,BROWN, Julien Alistair,CALMIANO, Mark Daniel,CHOVATIA, Praful Tulshi,DELIGNY, Michael,GALLIMORE, Ellen Olivia,HEER, Jag,JACKSON, Victoria Elizabeth,KROEPLIEN,
申请号:
ES14808658
公开号:
ES2755335T3
申请日:
2014.12.08
申请国别(地区):
ES
年份:
2020
代理人:
摘要:
A series of fused tricyclic imidazole derivatives, in particular dihydro-1H-cyclopenta[4,5]imidazo[1,2-a]pyridine derivatives, and analogues thereof, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充